Masimo Gross Profit 2007-2019 | MASI

Masimo annual/quarterly gross profit history and growth rate from 2007 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Masimo gross profit for the quarter ending December 31, 2019 was $0.167B, a 12.53% increase year-over-year.
  • Masimo gross profit for the twelve months ending December 31, 2019 was $0.629B, a 9.44% increase year-over-year.
  • Masimo annual gross profit for 2019 was $0.629B, a 9.44% increase from 2018.
  • Masimo annual gross profit for 2018 was $0.575B, a 10.13% increase from 2017.
  • Masimo annual gross profit for 2017 was $0.522B, a 9.13% increase from 2016.
Masimo Annual Gross Profit
(Millions of US $)
2019 $629
2018 $575
2017 $522
2016 $478
2015 $410
2014 $391
2013 $359
2012 $326
2011 $294
2010 $286
2009 $249
2008 $218
2007 $183
2006 $163
2005 $65
Masimo Quarterly Gross Profit
(Millions of US $)
2019-12-31 $167
2019-09-30 $156
2019-06-30 $154
2019-03-31 $152
2018-12-31 $148
2018-09-30 $141
2018-06-30 $142
2018-03-31 $144
2017-12-31 $139
2017-09-30 $124
2017-06-30 $127
2017-03-31 $132
2016-12-31 $139
2016-09-30 $110
2016-06-30 $115
2016-03-31 $114
2015-12-31 $102
2015-09-30 $102
2015-06-30 $103
2015-03-31 $103
2014-12-31 $109
2014-09-30 $96
2014-06-30 $93
2014-03-31 $92
2013-12-31 $91
2013-09-30 $87
2013-06-30 $91
2013-03-31 $90
2012-12-31 $87
2012-09-30 $78
2012-06-30 $81
2012-03-31 $79
2011-12-31 $74
2011-09-30 $68
2011-06-30 $75
2011-03-31 $77
2010-12-31 $74
2010-09-30 $72
2010-06-30 $70
2010-03-31 $70
2009-12-31 $66
2009-09-30 $62
2009-06-30 $60
2009-03-31 $61
2008-12-31 $59
2008-09-30 $56
2008-06-30 $53
2008-03-31 $50
2007-12-31 $49
2007-09-30 $46
2007-06-30 $46
2007-03-31 $42
2006-09-30 $43
2006-06-30 $41
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.714B $0.938B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $112.553B 22.87
Intuitive Surgical (ISRG) United States $53.993B 40.04
Edwards Lifesciences (EW) United States $39.539B 33.94
ALCON INC (ALC) Switzerland $24.415B 0.00
DexCom (DXCM) United States $23.883B 142.49
IDEXX Laboratories (IDXX) United States $20.016B 48.06
Fresenius Medical Care AG KGaA (FMS) Germany $19.254B 12.76
Olympus (OCPNY) Japan $17.845B 0.00
Sysmex ADR (SSMXY) Japan $14.493B 40.85
Teleflex (TFX) United States $13.650B 26.40
STERIS (STE) Ireland $11.765B 25.08
SONOVA HOLDING (SONVY) Switzerland $10.323B 0.00
Varian Medical Systems (VAR) United States $8.736B 20.33
Hologic (HOLX) United States $8.642B 13.29
SARTORIUS AG (SARTF) Germany $7.545B 67.04
ABIOMED (ABMD) United States $6.372B 33.59
Penumbra (PEN) United States $5.544B 163.05
Globus Medical (GMED) United States $3.974B 23.56
Tandem Diabetes Care (TNDM) United States $3.664B 0.00
Integra LifeSciences Holdings (IART) United States $3.498B 15.12
Wright Medical Group (WMGI) Netherlands $3.388B 376.00
Nihon Kohden (NHNKY) Japan $3.052B 0.00
Nevro (NVRO) United States $2.990B 0.00
Elekta AB (EKTAY) Sweden $2.961B 22.79
LivaNova (LIVN) United Kingdom $2.051B 14.96
Integer Holdings (ITGR) United States $1.701B 11.08
Cantel Medical (CMD) United States $1.288B 12.39
Glaukos (GKOS) United States $1.278B 0.00
Luminex (LMNX) United States $1.210B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.135B 22.21
Inogen (INGN) United States $1.122B 47.58
Veracyte (VCYT) United States $0.969B 0.00
Silk Road Medical (SILK) United States $0.943B 0.00
ShockWave Medical (SWAV) United States $0.937B 0.00
Mesa Laboratories (MLAB) United States $0.914B 47.83
OPKO Health (OPK) United States $0.777B 0.00
Natus Medical (NTUS) United States $0.713B 16.72
Tactile Systems Technology (TCMD) United States $0.689B 63.98
CryoLife (CRY) United States $0.667B 55.03
OrthoPediatrics (KIDS) United States $0.609B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.499B 17.69
Accelerate Diagnostics (AXDX) United States $0.411B 0.00
Pacific Biosciences Of California (PACB) United States $0.406B 0.00
AngioDynamics (ANGO) United States $0.362B 16.60
ViewRay (VRAY) United States $0.361B 0.00
Intersect ENT (XENT) United States $0.308B 0.00
AxoGen (AXGN) United States $0.305B 0.00
Si-Bone (SIBN) United States $0.300B 0.00
Quotient (QTNT) Switzerland $0.300B 0.00
GenMark Diagnostics (GNMK) United States $0.268B 0.00
TransMedics (TMDX) United States $0.252B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.250B 0.00
Semler Scientific (SMLR) United States $0.224B 26.73
IRadimed (IRMD) United States $0.223B 25.24
SeaSpine Holdings (SPNE) United States $0.203B 0.00
Alphatec Holdings (ATEC) United States $0.202B 0.00
Accuray (ARAY) United States $0.157B 0.00
Fluidigm (FLDM) United States $0.138B 0.00
Restoration Robotics (VERO) Canada $0.126B 0.00
RTI Surgical (RTIX) United States $0.110B 29.80
Sientra (SIEN) United States $0.091B 0.00
Spectral Diagnostics (EDTXF) Canada $0.082B 0.00
Vermillion (VRML) United States $0.076B 0.00
Allied Healthcare Products (AHPI) United States $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.061B 16.15
MRI Interventions (CLPT) United States $0.051B 0.00
Apollo Endosurgery (APEN) United States $0.046B 0.00
ConforMIS (CFMS) United States $0.042B 0.00
Sensus Healthcare (SRTS) United States $0.041B 0.00
Neuronetics (STIM) United States $0.026B 0.00
Bioanalytical Systems (BASI) United States $0.025B 0.00
T2 Biosystems (TTOO) United States $0.024B 0.00
Ra Medical Systems (RMED) United States $0.017B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.017B 0.00
DarioHealth (DRIO) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Neovasc (NVCN) Canada $0.014B 0.00
Second Sight Medical Products (EYES) United States $0.013B 0.00
Sunshine Heart Inc (CHFS) United States $0.011B 0.00
Nanovibronix (NAOV) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Dynatronics (DYNT) United States $0.009B 0.00
Lianluo Smart (LLIT) China $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
Helius Medical Technologies (HSDT) United States $0.007B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
ReWalk Robotics (RWLK) Israel $0.005B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00